News Archives | Welcome to Ardena

News
14.07.2021

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Read more
Citryll enters into bioanalytics partnership with Ardena for the clinical development of CIT-013, antagonist of NET biology and associated pathologies featured image

News
12.07.2021

Citryll enters into bioanalytics partnership with Ardena for the clinical development of CIT-013, antagonist of NET biology and associated pathologies

Read more
Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd. featured image

News
15.06.2021

Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd.

Read more

News
18.05.2021

Investment in Flow Cytometry unlocks the secrets of single cells

Read more
Press Release | New cancer immunotherapy treatment enters clinical phase featured image

News
27.04.2021

Press Release | New cancer immunotherapy treatment enters clinical phase

Read more

News
24.11.2020

Commercial Agency Agreement Taiwan (ROC)

Read more